New bladder cancer drug trial offers hope for patients who Can't get standard treatment
Disease control
Not yet recruiting
This study is testing whether a new treatment called TARA-002 works better than standard chemotherapy for adults with high-grade non-muscle invasive bladder cancer who haven't received BCG therapy. Researchers will give TARA-002 directly into the bladder and compare it to standar…
Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC